Chapter/Section Purchase

1 Study Coverage
1.1 Oncology Injection Drug Product Introduction
1.2 Global Oncology Injection Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Oncology Injection Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Oncology Injection Drug Sales in Volume for the Year 2017-2028
1.3 United States Oncology Injection Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Oncology Injection Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Oncology Injection Drug Sales in Volume for the Year 2017-2028
1.4 Oncology Injection Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Oncology Injection Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Oncology Injection Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Oncology Injection Drug Market Dynamics
1.5.1 Oncology Injection Drug Industry Trends
1.5.2 Oncology Injection Drug Market Drivers
1.5.3 Oncology Injection Drug Market Challenges
1.5.4 Oncology Injection Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Oncology Injection Drug Market Segment by Type
2.1.1 Organs
2.1.2 Central Nervous System
2.1.3 Circulatory/Musculoskeletal System
2.1.4 Other
2.2 Global Oncology Injection Drug Market Size by Type
2.2.1 Global Oncology Injection Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Oncology Injection Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Oncology Injection Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Oncology Injection Drug Market Size by Type
2.3.1 United States Oncology Injection Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Oncology Injection Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Oncology Injection Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Oncology Injection Drug Market Segment by Application
3.1.1 Lymphoma
3.1.2 Myeloma
3.1.3 Prostate Cancer
3.1.4 Other
3.2 Global Oncology Injection Drug Market Size by Application
3.2.1 Global Oncology Injection Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Oncology Injection Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Oncology Injection Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Oncology Injection Drug Market Size by Application
3.3.1 United States Oncology Injection Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Oncology Injection Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Oncology Injection Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oncology Injection Drug Competitor Landscape by Company
4.1 Global Oncology Injection Drug Market Size by Company
4.1.1 Top Global Oncology Injection Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Oncology Injection Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Oncology Injection Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Oncology Injection Drug Price by Manufacturer (2017-2022)
4.2 Global Oncology Injection Drug Concentration Ratio (CR)
4.2.1 Oncology Injection Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oncology Injection Drug in 2021
4.2.3 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Oncology Injection Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Oncology Injection Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Oncology Injection Drug Product Type
4.3.3 Date of International Manufacturers Enter into Oncology Injection Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Oncology Injection Drug Market Size by Company
4.5.1 Top Oncology Injection Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Oncology Injection Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Oncology Injection Drug Sales by Players (2020, 2021 & 2022)
5 Global Oncology Injection Drug Market Size by Region
5.1 Global Oncology Injection Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Oncology Injection Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Oncology Injection Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Oncology Injection Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Oncology Injection Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Oncology Injection Drug Sales in Value by Region: 2017-2022
5.3.2 Global Oncology Injection Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Oncology Injection Drug Market Size YoY Growth 2017-2028
6.1.2 North America Oncology Injection Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Oncology Injection Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Oncology Injection Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Oncology Injection Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Oncology Injection Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Oncology Injection Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Oncology Injection Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Oncology Injection Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Oncology Injection Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Taj Oncology
7.1.1 Taj Oncology Corporation Information
7.1.2 Taj Oncology Description and Business Overview
7.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Taj Oncology Oncology Injection Drug Products Offered
7.1.5 Taj Oncology Recent Development
7.2 S.G. Biopharm
7.2.1 S.G. Biopharm Corporation Information
7.2.2 S.G. Biopharm Description and Business Overview
7.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 S.G. Biopharm Oncology Injection Drug Products Offered
7.2.5 S.G. Biopharm Recent Development
7.3 AdvaCare
7.3.1 AdvaCare Corporation Information
7.3.2 AdvaCare Description and Business Overview
7.3.3 AdvaCare Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 AdvaCare Oncology Injection Drug Products Offered
7.3.5 AdvaCare Recent Development
7.4 Merrimack
7.4.1 Merrimack Corporation Information
7.4.2 Merrimack Description and Business Overview
7.4.3 Merrimack Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Merrimack Oncology Injection Drug Products Offered
7.4.5 Merrimack Recent Development
7.5 Celgene
7.5.1 Celgene Corporation Information
7.5.2 Celgene Description and Business Overview
7.5.3 Celgene Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Celgene Oncology Injection Drug Products Offered
7.5.5 Celgene Recent Development
7.6 Allos Therapeutics
7.6.1 Allos Therapeutics Corporation Information
7.6.2 Allos Therapeutics Description and Business Overview
7.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Allos Therapeutics Oncology Injection Drug Products Offered
7.6.5 Allos Therapeutics Recent Development
7.7 Ferring Pharmaceuticals
7.7.1 Ferring Pharmaceuticals Corporation Information
7.7.2 Ferring Pharmaceuticals Description and Business Overview
7.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Ferring Pharmaceuticals Oncology Injection Drug Products Offered
7.7.5 Ferring Pharmaceuticals Recent Development
7.8 Genzyme
7.8.1 Genzyme Corporation Information
7.8.2 Genzyme Description and Business Overview
7.8.3 Genzyme Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Genzyme Oncology Injection Drug Products Offered
7.8.5 Genzyme Recent Development
7.9 Eli Lilly
7.9.1 Eli Lilly Corporation Information
7.9.2 Eli Lilly Description and Business Overview
7.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Eli Lilly Oncology Injection Drug Products Offered
7.9.5 Eli Lilly Recent Development
7.10 Praecis Pharmaceuticals
7.10.1 Praecis Pharmaceuticals Corporation Information
7.10.2 Praecis Pharmaceuticals Description and Business Overview
7.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Praecis Pharmaceuticals Oncology Injection Drug Products Offered
7.10.5 Praecis Pharmaceuticals Recent Development
7.11 Millennium Pharmaceuticals
7.11.1 Millennium Pharmaceuticals Corporation Information
7.11.2 Millennium Pharmaceuticals Description and Business Overview
7.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Millennium Pharmaceuticals Oncology Injection Drug Products Offered
7.11.5 Millennium Pharmaceuticals Recent Development
7.12 Debiopharm
7.12.1 Debiopharm Corporation Information
7.12.2 Debiopharm Description and Business Overview
7.12.3 Debiopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Debiopharm Products Offered
7.12.5 Debiopharm Recent Development
7.13 Alza
7.13.1 Alza Corporation Information
7.13.2 Alza Description and Business Overview
7.13.3 Alza Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Alza Products Offered
7.13.5 Alza Recent Development
7.14 CordenPharma
7.14.1 CordenPharma Corporation Information
7.14.2 CordenPharma Description and Business Overview
7.14.3 CordenPharma Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.14.4 CordenPharma Products Offered
7.14.5 CordenPharma Recent Development
7.15 Pharmascience
7.15.1 Pharmascience Corporation Information
7.15.2 Pharmascience Description and Business Overview
7.15.3 Pharmascience Oncology Injection Drug Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Pharmascience Products Offered
7.15.5 Pharmascience Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Oncology Injection Drug Industry Chain Analysis
8.2 Oncology Injection Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Oncology Injection Drug Distributors
8.3 Oncology Injection Drug Production Mode & Process
8.4 Oncology Injection Drug Sales and Marketing
8.4.1 Oncology Injection Drug Sales Channels
8.4.2 Oncology Injection Drug Distributors
8.5 Oncology Injection Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer